|
|
|
Volumn 24, Issue 5 SUPPL. 15, 1997, Pages
|
|
Paclitaxel, estramustine, and etoposide in the treatment of hormone- refractory prostate cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA TOPOISOMERASE (ATP HYDROLYSING);
ESTRAMUSTINE;
ETOPOSIDE;
PACLITAXEL;
PROSTATE SPECIFIC ANTIGEN;
ALOPECIA;
ASTHENIA;
CELL NUCLEUS MATRIX;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOSKELETON;
CYTOTOXICITY;
DNA PROTEIN COMPLEX;
DNA REPLICATION;
DNA SYNTHESIS;
DRUG POTENTIATION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MICROTUBULE;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN RNA BINDING;
ADENOCARCINOMA;
ADMINISTRATION, ORAL;
ALOPECIA;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DISEASE PROGRESSION;
DNA REPLICATION;
DNA, NEOPLASM;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, NEOPLASM;
DRUG SCREENING ASSAYS, ANTITUMOR;
ESTRAMUSTINE;
ETOPOSIDE;
FOLLOW-UP STUDIES;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MICROTUBULES;
NUCLEAR MATRIX;
PACLITAXEL;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RATS;
REMISSION INDUCTION;
TUMOR CELLS, CULTURED;
|
|
EID: 17444436904
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (25)
|
|
References (39)
|
